Science Current Events | Science News | Brightsurf.com
 

Wild gorillas carriers of a SIV virus close to the AIDS virus

November 14, 2006
In 2005, 40.3 million people in the world, including 25.8 million in Sub-Saharan Africa, were living with HIV. The question of the origin of HIV-1, responsible for the AIDS pandemic, has been stimulating the scientific community for many years.

Some months ago, the team of Martine Peeters, director of research at IRD, and Eric Delaporte, director of the mixed research unit UMR 145 jointly involving the IRD and the University of Montpellier 1, showed the chimpanzee subspecies living in the Congo Basin (2) to be the reservoir of HIV-1 virus group M, the source of the world pandemic and that of another, very rare variant, HIV-1 group N. However, the reservoir of the third HIV-1 group, group O which infects humans (3), remained unidentified up to now.

This team announces, in an article in the journal Nature, the discovery of a simian immunodeficiency virus (SIV) infection in wild gorillas. Samples of faeces collected from different communities of gorillas found in the remotest areas of the Cameroon tropical forest were found to contain antibodies against this virus, called SIVgor. The genetic characteristics of the virus were present again in three gorillas living more than 400 km apart. Phylogenetic analysis of SIVgor showed it to be related to HIV-1 group O found in humans, essentially in Cameroon and in neighbouring countries.

This discovery of an HIV-1 related virus in wild gorillas does not, however, call into question the fact that chimpanzees are the primary reservoir of SIV/HIV viruses that crop up again in gorillas and in humans. As Martine Peeters of the IRD says, "the viruses of groups M and N are, very clearly, the consequence of inter-species transmission from chimpanzee to humans, whereas the origin of HIV-1 group O is less apparent. It cannot be excluded that chimpanzees infected by HIV-1 group O might have contaminated humans and the gorilla independently, or that the gorilla, having been contaminated by the chimpanzee, might have contaminated humans".

This work thus opens up a Pandora's box on the questions and speculations concerning the ability of these viruses to cross over from one species to another. The main challenges facing these teams for future work will be determination of the prevalence, the geographical distribution and biology of SIV infections in these great apes, not forgetting the question of how the gorillas were contaminated. This last point remains a mystery,considered as rare.

1. UMR 145: Fran Van Heuverswijn, Cecile Neel, Florian Liegeois, Christelle Butel, Eric Delaporte and Martine Peeters jointly involving the IRD and the University of Montpellier1 University of Alabama (Beatrice Hahn and her colleagues), University of Nottingham (Paul Sharp and his colleagues) PRESICA Project of Cameroon headed by Eitel Mpoudi-Ngole.

2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngole E, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 2006 , 313 : 523-6

3. Scientists have known for a long time that the Aids virus shows a very strong genetic variability. Two main types of the virus exist: HIV 1 and HIV 2. HIV 1, the most widely spread in the world, embraces three groups (M, N,O) which manifest different genetic characteristics. Within group M, the most frequent, still 9 further subtypes can be distinguished (A, B, C, D, F, G, H, J, K), genetically close yet distinct.

Institut de Recherche Pour le Développement


Related Hiv-1 Current Events and Hiv-1 News Articles


Researchers 'un-can' the HIV virus
If the human immunodeficiency virus (HIV) is a bit like a hermetically sealed tin can no one has yet been able to break open, the good news is that researchers at the CHUM Research Centre, affiliated with the University of Montreal, have identified a way to use a "can opener" to force the virus to open up and to expose its vulnerable parts, allowing the immune system cells to then kill the infected cells.

Study reveals how a Rab protein controls HIV-1 replication
HIV-1 replication requires the coordinated movement of the virus's components toward the plasma membrane of an immune cell, where the virions are assembled and ultimately released.

Optimizing treatment protocols when diagnostics are costly
HIV-1 continues to spread globally. While neither a cure, nor an effective vaccine are available, recent focus has been put on 'treatment-for-prevention', which is a method by which treatment is used to reduce the contagiousness of an infected person.

Ebola analysis finds virus hasn't become deadlier, yet
Research from The University of Manchester using cutting edge computer analysis reveals that despite mutating, Ebola hasn't evolved to become deadlier since the first outbreak 40 years ago.

Human immune system can control re-awakened HIV, suggesting cure is possible
The human immune system can handle large bursts of HIV activity and so it should be possible to cure HIV with a 'kick and kill' strategy, finds new research led by UCL, the University of Oxford and the University of North Carolina at Chapel Hill.

Epidemiology of HIV-1 transmitted drug resistance
Only a limited number of surveillance drug-resistance mutations (SDRMs) are responsible for most instances of non-nucleoside reverse transcriptase inhibitor (NNRTI)- and nucleoside reverse transcriptase inhibitor (NRTI)-associated resistance, and most strains of HIV-1 transmitted drug resistance (TDR) in sub-Saharan Africa (SSA) and south/southeast Asia (SSEA) arose independently.

UCLA research links HIV to age-accelerating cellular changes
People undergoing treatment for HIV-1 have an increased risk for earlier onset of age-related illnesses such as some cancers, renal and kidney disease, frailty, osteoporosis and neurocognitive disease. But is it because of the virus that causes AIDS or the treatment?

New model finds HIV acute phase infectivity may be lower than previously estimated
Previous calculations may have overestimated the importance of HIV transmission from recently infected individuals ("acute phase infectivity") in driving HIV epidemics, according to an article published by Steve Bellan of The University of Texas at Austin, and colleagues in this week's PLOS Medicine.

Common herpes medication reduces HIV-1 levels, independent of herpes infection
Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels -- even when patients do not have herpes.

Postoperative mortality rates low among patients with HIV prescribed ART
ostoperative mortality rates were low among patients infected with the human immunodeficiency virus (HIV) who are receiving antiretroviral therapy (ART), and those mortality rates were influenced as much by age and poor nutritional status as CD4 cell counts.
More Hiv-1 Current Events and Hiv-1 News Articles

Living With HIV- The Essential Guide to Managing and Healing HIV & AIDS Symptoms (HIV essentials, AIDS research, HIV research, HIV test, AIDS virus, HIV ... HIV infection, HIV AIDS, AIDS HIV Book 1)

Living With HIV- The Essential Guide to Managing and Healing HIV & AIDS Symptoms (HIV essentials, AIDS research, HIV research, HIV test, AIDS virus, HIV ... HIV infection, HIV AIDS, AIDS HIV Book 1)


Discover How To Effectively Manage and Heal HIV and AIDS Symptoms So It Can Have A Minimal Impact On Your Life Or The Life Of A Loved One

Today only, get this eBook for just $0.99. Regularly priced at $4.99. Read on your PC, Mac, smart phone, tablet or Kindle device.

Being HIV positive is no longer a death sentence. This book contains proven steps and strategies on how you or a loved one can cope with being diagnosed as HIV positive, as well as the relevant treatments, and frequently asked questions. By properly managing the condition and taking medication correctly, there is no reason why those living with HIV cannot live as normal a life as possible!

HIV is a well-documented, progressive medical condition. When someone becomes infected with HIV and...

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)
by imstilljosh.com


Learning you are HIV-positive is a pretty scary time in a person's life. Josh Robbins found out that he was living with HIV in the beginning of 2012 and started an online journey encouraging others that are living with the virus to keep their mind and spirit in a good place. His main method of offering that encouragement? By sharing images. This coffee-table formatted book shares the images that Josh Robbins of imstilljosh.com uses to fight HIV stigma.

The First Year: HIV: An Essential Guide for the Newly Diagnosed

The First Year: HIV: An Essential Guide for the Newly Diagnosed
by Brett Grodeck (Author), M.D. Daniel S. Berger M.D. (Foreword)


This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)
by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor)


This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting.

HIV-1 Integrase: Mechanism and Inhibitor Design

HIV-1 Integrase: Mechanism and Inhibitor Design
by Nouri Neamati (Editor), Binghe Wang (Editor)


This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.

In Sickness and In Health (Terminal Book 1)

In Sickness and In Health (Terminal Book 1)
by Lazy Beagle Entertainment


David has been HIV positive for four years now. His friends and family keep walking away from him. He grows bitter and lonely and sinks into a depression so low he is determined to just fade away and die.

Louis is the father of two sons and is raising them alone after his husband died three years before. Out with friends one night he lays eyes on David.

Together the two begin a whirlwind journey through life. Love, marriage, children, and tragedies along the way fill their lives. Can David let go of the feelings from the past and move forward and love? Can Louis's heart survive this relationship? Being terminal is no longer an obstacle to love.

HIV/AIDS: A Very Short Introduction (Very Short Introductions)

HIV/AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)


HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means...

AIDS in New York: The First Five Years

AIDS in New York: The First Five Years
by Jean Ashton (Author)



New York lived in fear. In the early 1980s, a mysterious infectious disease began to kill gays, their partners, and children, as well as injected drug users and blood transfusion patients. Then unnamed, with research funding and support for the dying unavailable, the HIV/AIDS virus would eventually take nearly one hundred million lives.

With America's largest gay population, New York was hit early and hard by AIDS. And a silent City Hall and sensationalist tabloid headlines spread homophobia and panic. Yet within months the city's gay community and concerned medical professionals mobilized, fighting disinformation and attacks on sufferers' civil liberties, and lobbying for funds for medical and social outreach.

In forceful narrative and vivid images, AIDS...

Living With HIV and AIDS: Prevention, Healing Symptoms, the Newest Treatments, and Possible Cures (Health Book 1)

Living With HIV and AIDS: Prevention, Healing Symptoms, the Newest Treatments, and Possible Cures (Health Book 1)


The Definitive Guide To HIV/AIDS
Living with HIV or AIDS can be extremely difficult, not only because of the stigma but because of the medical treatments which, while they are advancing every day, have a ways to go. This book tells you everything to know about HIV/AIDS, including everything from infection to the different stages of the disease to the innovative new treatments that are starting to become available (some as new as March 2014!).

"It is bad enough that people are dying of AIDS, but no one should die of ignorance." - Elizabeth Taylor

Here Is A Preview Of What You'll Learn...
How HIV and AIDS work in the bodyHow infection occurs, and several strategies at preventionManaging symptoms of HIV, and preventing it from turning into AIDSModern...

HIV/AIDS and the Drug Culture: Shattered Lives

HIV/AIDS and the Drug Culture: Shattered Lives
by Joan Gormley (Author), Elizabeth Hagan (Author)


In this startling new collection of case studies entitled HIV/AIDS and the Drug Culture: Shattered Lives, you’ll take an eye-opening and informative look at the lifestyle and culture of the HIV/AIDS intravenous drug users (IVDUs). You’ll see how health care providers and caregivers can update their methods and mindsets in order to meet the needs of this special cross-section of patients.

In each chapter of HIV/AIDS and the Drug Culture, you’ll gain instant access to full medical and psychosocial histories. You’ll also find summaries of important events, clues to recognize, and strategies to safely manage each problematic situation that might arise, all of which will speed you on your way to more effectively and professionally administering to current and former...

© 2015 BrightSurf.com